Optimizing hematopoietic recovery following bone marrow transplantation

Por Paquette, Ronald, Dorshkind, Kenneth
Publicado em 2002

Dasatinib 100 mg Once Daily Minimizes the Occurrence of Pleural Effusion in Patients With Chronic Myeloid Leukemia in Chronic Phase and Efficacy Is Unaffected in Patients who Devel...

Por Porkka, Kimmo, Khoury, H. Jean, Paquette, Ronald L., Matloub, Yousif, Sinha, Ritwik, Cortes, Jorge E.
Publicado em 2010

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

Por Gabrilove, Janice, Paquette, Ronald, Lyons, Roger M, Mushtaq, Chaudhry, Sekeres, Mikkael A, Tomita, Dianne, Dreiling, Lyndah
Publicado em 2008

Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys

Por Sekeres, Mikkael A., Schoonen, W. Marieke, Kantarjian, Hagop, List, Alan, Fryzek, Jon, Paquette, Ronald, Maciejewski, Jaroslaw P.
Publicado em 2008

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Dasatinib

Por Paquette, Ronald L., Nicoll, John, Chalukya, Meenal, Gondek, Lucas, Jasek, Monika, Sawyers, Charles L., Shah, Neil P., Maciejewski, Jaroslaw
Publicado no Leuk Res (2009)

Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency

Por Shah, Neil P., Skaggs, Brian J., Branford, Susan, Hughes, Timothy P., Nicoll, John M., Paquette, Ronald L., Sawyers, Charles L.
Publicado em 2007

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

Por O'Connell, Ryan M., Rao, Dinesh S., Chaudhuri, Aadel A., Boldin, Mark P., Taganov, Konstantin D., Nicoll, John, Paquette, Ronald L., Baltimore, David
Publicado em 2008

Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes

Por Sekeres, Mikkael A., List, Alan F., Cuthbertson, David, Paquette, Ronald, Ganetsky, Rebecca, Latham, Deborah, Paulic, Katarina, Afable, Manuel, Saba, Hussain I., Loughran, Thomas P., Maciejewski, Jaroslaw P.
Publicado em 2010

Expansion of Effector Memory Regulatory T-cells Represents A Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome

Por Mailloux, Adam W, Sugimori, Chiharu, Komrokji, Rami S., Yang, Lili, Maciejewski, Jaroslaw P., Sekeres, Mikkael A., Paquette, Ronald, Loughran, Thomas P., List, Alan F., Epling-Burnette, P.K.
Publicado em 2012

Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study: Efficacy and Tolerability of 140 Milli...

Por Saglio, Giuseppe, Hochhaus, Andreas, Goh, Yeow Tee, Masszi, Tamas, Pasquini, Ricardo, Maloisel, Frederic, Erben, Philipp, Cortes, Jorge, Paquette, Ronald, Bradley-Garelik, M. Brigid, Zhu, Chao, Dombret, Herve
Publicado no Cancer (2010)

A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction

Por Komrokji, Rami S., Mailloux, Adam W., Chen, Dung-Tsa, Sekeres, Mikkael A., Paquette, Ronald, Fulp, William J., Sugimori, Chiharu, Paleveda-Pena, Jennifer, Maciejewski, Jaroslaw P., List, Alan F., Epling-Burnette, Pearlie K.
Publicado em 2014

Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia

Por Clemente, Michael J., Wlodarski, Marcin W., Makishima, Hideki, Viny, Aaron D., Bretschneider, Isabell, Shaik, Mohammad, Bejanyan, Nelli, Lichtin, Alan E., His, Eric D., Paquette, Ronald L., Loughran, Thomas P., Maciejewski, Jaroslaw P.
Publicado em 2011

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

Por Verstovsek, Srdan, Gotlib, Jason, Mesa, Ruben A., Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Cervantes, Francisco, Harrison, Claire N., Paquette, Ronald, Sun, William, Naim, Ahmad, Langmuir, Peter, Dong, Tuochuan, Gopalakrishna, Prashanth, Gupta, Vikas
Publicado no J Hematol Oncol (2017)

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

Por Stone, Richard M., Fischer, Thomas, Paquette, Ronald, Schiller, Gary, Schiffer, Charles A., Ehninger, Gerhard, Cortes, Jorge, Kantarjian, Hagop M., DeAngelo, Daniel J., Huntsman-Labed, Alice, Dutreix, Catherine, del Corral, Adam, Giles, Francis
Publicado em 2012

Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia

Por Sun, Haibo, Lin, De-Chen, Guo, Xiao, Masouleh, Behzad Kharabi, Gery, Sigal, Cao, Qi, Alkan, Serhan, Ikezoe, Takayuki, Akiba, Chie, Paquette, Ronald, Chien, Wenwen, Müller-Tidow, Carsten, Jing, Yang, Agelopoulos, Konstantin, Müschen, Markus, Koeffler, H. Phillip
Publicado no Oncotarget (2016)

Correction: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia

Por Sun, Haibo, Lin, De-Chen, Guo, Xiao, Masouleh, Behzad Kharabi, Gery, Sigal, Cao, Qi, Alkan, Serhan, Ikezoe, Takayuki, Akiba, Chie, Paquette, Ronald, Chien, Wenwen, Müller-Tidow, Carsten, Jing, Yang, Agelopoulos, Konstantin, Müschen, Markus, Koeffler, H. Phillip
Publicado no Oncotarget (2017)

Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies

Por Makishima, Hideki, Cazzolli, Heather, Szpurka, Hadrian, Dunbar, Andrew, Tiu, Ramon, Huh, Jungwon, Muramatsu, Hideki, O'Keefe, Christine, Hsi, Eric, Paquette, Ronald L., Kojima, Seiji, List, Alan F., Sekeres, Mikkael A., McDevitt, Michael A., Maciejewski, Jaroslaw P.
Publicado em 2009

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

Por Makishima, Hideki, Jankowska, Anna M., McDevitt, Michael A., O'Keefe, Christine, Dujardin, Simon, Cazzolli, Heather, Przychodzen, Bartlomiej, Prince, Courtney, Nicoll, John, Siddaiah, Harish, Shaik, Mohammed, Szpurka, Hadrian, Hsi, Eric, Advani, Anjali, Paquette, Ronald, Maciejewski, Jaroslaw P.
Publicado em 2011

Naïve T-cells in Myelodysplastic Syndrome Display Intrinsic Human Telomerase Reverse Transcriptase (hTERT) Deficiency

Por Yang, Lili, Mailloux, Adam, Rollison, Dana E., Painter, Jeffrey S., Maciejewski, Jaroslaw, Paquette, Ronald L., Loughran, Thomas P., McGraw, Kathy, Makishima, Hideki, Radhakrishnan, Rangasudhagar, Wei, Sheng, Ren, Xiubao, Komrokji, Rami, List, Alan F., Epling-Burnette, P.K.
Publicado no Leukemia (2012)

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies

Por Tiu, Ramon V., Gondek, Lukasz P., O'Keefe, Christine L., Elson, Paul, Huh, Jungwon, Mohamedali, Azim, Kulasekararaj, Austin, Advani, Anjali S., Paquette, Ronald, List, Alan F., Sekeres, Mikkael A., McDevitt, Michael A., Mufti, Ghulam J., Maciejewski, Jaroslaw P.
Publicado em 2011